₹537.65
+13.45 (+2.57%)
As of 18 Sept 2026, Unichem Laboratories Ltd share price is ₹537.65. The stock opened at ₹537.65 and had closed at ₹524.20 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹280.00 and a high of ₹685.95. In terms of performance, Unichem Laboratories Ltd share price has increased by 72.88% over the past six months and has increased by 6.92% over the last year.
UNICHEMLAB Stock Price Chart
Unichem Laboratories Ltd Overview
Market cap₹3,785 Crs
Volume4,907
Prev. Close₹524.20
Year range₹280.00 - ₹685.95
ISININE351A01035
About UNICHEMLAB
Unichem Laboratories engaged in manufacturing of pharmaceutical products.
Unichem Laboratories Ltd Historical Performance
1 Month Return-0.94%
6 Month Return74.34%
3 Year Return31.49%
3 Month Return19.42%
1 Year Return6.55%
5 Year Return97.63%
Unichem Laboratories Ltd Fundamentals
ROCE(TTM)-0.21%
P/E Ratio (TTM)22.76
P/B Ratio1.44
Debt to Equity0.02
ROE-0.67%
EPS (TTM)0.00
Dividend Yield0.00%
Book Value373.14
Profit Margin-1.90%
Operating Margin-5.42%
Unichem Laboratories Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 1,475.19 | 1,776.53 | 1,472.55 | 1,114.28 | 985.00 |
| EBITDA | 340.24 | 298.71 | 23.69 | -163.73 | -1.49 |
| Net Profit | 158.94 | 162.96 | -92.18 | -299.70 | -55.43 |
| EPS | 22.57 | 23.15 | -13.09 | -42.57 | -7.87 |
Unichem Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 504.43 |
| Resistance 1 (R1) | 538.78 |
| Pivot Point | 519.02 |
Unichem Laboratories Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 01-Aug-2022 | 27-May-2022 | 03-Aug-2022 | Final | ₹4.00 |
| 22-Jul-2021 | 29-May-2021 | 26-Jul-2021 | Final | ₹4.00 |
UNICHEMLAB Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Prakash A Mody | Chairman |
| Pabitra Bhattacharya | Managing Director & Chief Executive Officer |
| Pranay Godha | Non Executive Independent Director |
Unichem Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Unichem Laboratories Ltd today is ₹537.65 on NSE and ₹537.65 on BSE.
- The 52-week high of Unichem Laboratories Ltd is ₹685.95, while the 52-week low is ₹280.00.
- The current market capitalisation of Unichem Laboratories Ltd is approximately ₹3,785 crore.
- The P/E (Price-to-Earnings) ratio of Unichem Laboratories Ltd is 7.67. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Unichem Laboratories Ltd is 0.93. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Unichem Laboratories Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for UNICHEMLAB on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Unichem Laboratories Ltd has delivered a return of approximately 31.49%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Unichem Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 70.22% promoters, -8.41% FIIs, 10.46% DIIs, and 15.59% public shareholders.

